AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

White House World AIDS Day Observance Features Release of National HIV/AIDS Strategy Federal Action Plan

Valdiserri - Dec 4 blog

The White House hosted a World AIDS Day observance on Tuesday, December 1, 2015, welcoming domestic and global leaders in the fight against HIV/AIDS. Gathered under the theme “The time to act is now,” various presenters highlighted key actions underway or about to begin here in the U.S. and around the globe. The event opened…

Criteria Published for Research into Organ Transplantation from One Person with HIV to Another

Ronald Valdiserri

Federal partners recently took two important steps that will allow scientists to carry out research on organ donations from HIV-positive donors into HIV-positive recipients as authorized by the HIV Organ Policy Equity (HOPE) Act. As required under the Act, the Organ Procurement and Transplantation Network (OPTN) and the National Institutes of Health (NIH) have each…

NIH Statement on World AIDS Day 2015: Follow the Science to Fast-Track the End of AIDS

nih logo

When the first cases of what would become known as AIDS were reported in 1981, scientists and physicians did not know the cause and had no therapies to treat those who were infected. Times have changed and today physicians can offer their patients highly effective medicines that work as both treatment and prevention. We can…

FDA Issues Final Industry Guidance for Developing Antiretroviral Drugs for HIV Treatment

FDA

This week, FDA announced the availability of a final guidance [PDF 610 KB] for industry entitled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment.” The guidance provides recommendations for the development of antiretroviral drugs regulated within the FDA Center for Drug Evaluation and Research for the treatment of HIV infection. This guidance assists sponsors in…

FDA approves new treatment for HIV

FDA

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living…

New Coating for HIV Drug Holds Promise for Patients

VOA blog - pill image

Managing HIV could get a lot easier with a new delivery system for anti-AIDS drugs. Instead of daily pills, the treatment could lead to drugs that can be administered just once or twice per year. The new delivery system, designed at the University of Nebraska Medical Center, starts with protease inhibitors, the antiretroviral drugs commonly…

HHS & NIH Seek Public Comments on LGBT Health

HHS Logo

There are two opportunities to offer public comment on plans to better understand and improve the health and wellness of lesbian, gay, bisexual and transgender (LGBT) Americans. These federal plans include but extend beyond HIV, addressing many other health concerns of the LGBT community. NIH LGBT Research Strategic Plan The National Institutes of Health (NIH)…

Spotlight on the Updated National HIV/AIDS Strategy at USCA 2015

COi3mh0XAAQgv3w

The National HIV/AIDS Strategy: Updated to 2020 was in the spotlight during a plenary session of the 2015 U.S. Conference on AIDS in Washington, DC, yesterday (September 10, 2015). The annual conference, sponsored by the National Minority AIDS Council , has assembled nearly 3,000 participants from across the country in Washington, DC. ONAP Director Brooks Issues…